Hypertension Clinical Trial
Official title:
The Halland Obesity Municipal Effort for Children
NCT number | NCT05254938 |
Other study ID # | 4294300 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | January 1, 2019 |
Est. completion date | December 31, 2022 |
A retrospective study to investigate the method called The Halland Obesity Municipal Effort for children. All children participating in the intervention since the start of this specific method will be eligible for inclusion. The aims are to describe participants and the method-specific activities they are participating in, as well as the effect on their health and school grades.
Status | Recruiting |
Enrollment | 200 |
Est. completion date | December 31, 2022 |
Est. primary completion date | March 10, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 5 Years to 21 Years |
Eligibility | Inclusion Criteria: - Patients involved in the HOME project since the start. Children that have been offered this intense intervention. Exclusion Criteria: Those who are not willing to participate. - |
Country | Name | City | State |
---|---|---|---|
Sweden | Lovisa Sjögren | Särö |
Lead Sponsor | Collaborator |
---|---|
Göteborg University | Region Halland |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | 12 years completed education | Registry data regarding completion of 12 school years, will be assessed for each patients at the age of 19. | At the age of 19. | |
Primary | Change from baseline in BMI after 6 month | BMI (weight/height^2), obtained from health records at interventions start and after 6 months of intervention. | Baseline and month 6. | |
Primary | Change from baseline in BMI after 12 month | BMI (weight/height^2), obtained from health records at interventions start and after one year of intervention. | Baseline and month 12. | |
Primary | Change from baseline in BMI after 18 months | BMI (weight/height^2), obtained from health records at interventions start and after 18 months of intervention. | Baseline and month 18. | |
Primary | Change from baseline in gucose homeostasis | Blood samples concerning blood sugar levels (HbA1c, fasting glucose, insulin). Obtained from health records at interventions start and after one year of intervention. | Baseline and month 12. | |
Primary | Change from baseline in blood pressure | Blood pressure (mm/Hg) measured in right arm sitting down after 5 minutes of rest. Obtained from health records at interventions start and after one year of intervention. | Baseline and month 12. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |